Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results

Cyclacel Pharma (CYCC) Posts Wider Q2 Loss

August 12, 2020 4:10 PM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($2.13), $1.66 worse than the analyst estimate of ($0.47).

The Company's net loss applicable to common shareholders for the three months ended June 30, 2020 was $2.2 million. As of June 30, 2020, cash and cash equivalents totaled $25.3 million. Based on current spending, the Company estimates it has sufficient resources to fund planned operations, including... More